Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Manfred Windisch

Institute of Experimental Pharmacology

JSW Research

Austria

[email]@jswresearch.com

Name/email consistency: high

[Claim this account]

Affiliations

Institute of Experimental Pharmacology, JSW Research, Austria. 2008
JSW-Research, Institute of experimental Pharmacology, Rankengasse 28a, A-8020 Graz, Austria. 2002 - 2008
JSW-Research Forschungslabor GmbH, Austria. 2002 - 2005

References

The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies? Windisch, M., Wolf, H., Hutter-Paier, B., Wronski, R. Neurodegener. Dis (2008) [Pubmed]
Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders? Windisch, M., Wolf, H.J., Hutter-Paier, B., Wronski, R. Curr. Alzheimer. Res (2007) [Pubmed]
Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders? Windisch, M., Wolf, H.J., Hutter-Paier, B., Hofmeister, A., Wronski, R. Curr. Alzheimer. Res (2007) [Pubmed]
N-PEP-12--a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions. Windisch, M., Hutter-Paier, B., Grygar, E., Doppler, E., Moessler, H. J. Neural. Transm (2005) [Pubmed]
Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?. Windisch, M., Hutter-Paier, B., Schreiner, E., Wronski, R. J. Mol. Neurosci. (2004) [Pubmed]
The protective effect of ganstigmine against amyloid beta 25-35 neurotoxicity on chicken cortical neurons is independent from the cholinesterase inhibition. Windisch, M., Hutter-Paier, B., Jerkovic, L., Imbimbo, B., Villetti, G. Neurosci. Lett. (2003) [Pubmed]
Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides. Windisch, M., Hutter-Paier, B., Rockenstein, E., Hashimoto, M., Mallory, M., Masliah, E. J. Mol. Neurosci. (2002) [Pubmed]
Current drugs and future hopes in the treatment of Alzheimer's disease. Windisch, M., Hutter-Paier, B., Schreiner, E. J. Neural Transm. Suppl. (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.